| J9271 | Injection, pembrolizumab, 1 mg | 6,400 | $40 | $281.6K |
| Q5118 | Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 2,000 | $20 | $46K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 270 | $90 | $25.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 170 | $100 | $16.2K |
| 58571 | The provider incises all of the uterine, ovarian, and cervical connections through a laparoscope, and removes the uterus, cervix, and fallopian tubes, with or without the ovaries via the trocar ports… | 20 | $690 | $12.3K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 40 | $160 | $5.7K |
| J0185 | Injection, aprepitant, 1 mg | 5,070 | $1 | $5.1K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 70 | $50 | $3.6K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 260 | $10 | $3.1K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 140 | $20 | $2.9K |